Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate with or without pulse prednisolone for lichen planopilaris
IRCT20190911044742N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in lichen planopilaris (LPP) comparing Methotrexate with Methotrexate + pulse prednisolone (2 arms). Primary endpoints: LPPAI symptom and sign components and Photographic global assessment. Started Apr 2018; status: completed.
02
Drugs
methotrexateprednisolone
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on IRCT20190911044742N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190911044742N1.